Harvard Bioscience Inc
HBIO- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001123494
No open-market purchases or sales by Harvard Bioscience Inc insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $10.3M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Harvard Bioscience Inc as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- −26 vs. Q4 2025
- Shares held
- 1.59M
- +31.8K (+2.0%) vs. Q4 2025Converted for a 1-for-10 split
- Total value
- $7.73M
- −$2.67M (−25.7%) vs. Q4 2025
- New holders
- 3
- 10 more added
- Sold out
- 29
- 12 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 37 | $10.3M |
| Q1 2026 | 37 | $7.73M |
| Q4 2025 | 64 | $11.7M |
| Q3 2025 | 61 | $7.29M |
| Q2 2025 | 69 | $8.39M |
| Q1 2025 | 92 | $14.5M |
| Q4 2024 | 96 | $65.5M |
| Q3 2024 | 95 | $84.2M |
| Q2 2024 | 100 | $90.7M |
| Q1 2024 | 90 | $137.8M |
| Q4 2023 | 93 | $176.4M |
| Q3 2023 | 94 | $141.6M |
| Q2 2023 | 100 | $178.2M |
| Q1 2023 | 66 | $127.2M |
| Q4 2022 | 68 | $83.3M |
| Q3 2022 | 79 | $74.0M |
| Q2 2022 | 91 | $106.8M |
| Q1 2022 | 98 | $187.3M |
| Q4 2021 | 103 | $211.4M |
| Q3 2021 | 99 | $191.7M |
| Q2 2021 | 99 | $232.3M |
| Q1 2021 | 87 | $144.2M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Harvard Bioscience Inc; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Weber Capital Management LLC | 320,037 | $1.56M | 1.56% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Acadian Asset Management LLC | 179,614 | $873.0K | 0.00% | +2,351+1.3% | AddedConverted for a 1-for-10 split |
| Vanguard Capital Management LLC | 163,313 | $795.3K | 0.00% | +163,313 | New |
| Corsair Capital Management, L.P. | 124,810 | $607.8K | 0.09% | +13,941+12.6% | AddedConverted for a 1-for-10 split |
| Meros Investment Management, LP | 118,522 | $577.2K | 0.25% | −3,241−2.7% | ReducedConverted for a 1-for-10 split |
| Nano Cap New Millennium Growth Fund L P | 117,500 | $572.2K | 0.53% | +57,500+95.8% | AddedConverted for a 1-for-10 split |
| Two Sigma Investments, LP | 114,117 | $555.8K | 0.00% | +12,875+12.7% | AddedConverted for a 1-for-10 split |
| Renaissance Technologies LLC | 101,427 | $493.9K | 0.00% | −697−0.7% | ReducedConverted for a 1-for-10 split |
| BlackRock, Inc. | 62,226 | $303.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Geode Capital Management, LLC | 59,511 | $289.9K | 0.00% | +13,432+29.1% | AddedConverted for a 1-for-10 split |
| Millennium Management LLC | 46,332 | $225.6K | 0.00% | −8,275−15.2% | ReducedConverted for a 1-for-10 split |
| Williams & Novak, LLC | 27,052 | $137.7K | 0.10% | −7,828−22.4% | ReducedConverted for a 1-for-10 split |
| Vanguard Fiduciary Trust Co | 27,730 | $135.0K | 0.00% | +27,730 | New |
| Essex Investment Management Co LLC | 27,021 | $131.6K | 0.02% | +8,553+46.3% | AddedConverted for a 1-for-10 split |
| Jane Street Group, LLC | 23,830 | $116.1K | 0.00% | −17,686−42.6% | ReducedConverted for a 1-for-10 split |
| RBF Capital, LLC | 16,000 | $77.9K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| State Street Corp | 14,932 | $72.7K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Bank of New York Mellon Corp | 10,230 | $49.8K | 0.00% | −2,392−19.0% | ReducedConverted for a 1-for-10 split |
| UBS Group AG | 8,405 | $40.9K | 0.00% | +6,284+296.2% | AddedConverted for a 1-for-10 split |
| Citigroup Inc | 6,273 | $30.6K | 0.00% | −13,110−67.6% | ReducedConverted for a 1-for-10 split |
| JPMorgan Chase & Co | 4,463 | $20.8K | 0.00% | +4,267+2,177.0% | AddedConverted for a 1-for-10 split |
| FMR LLC | 3,274 | $15.9K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Group One Trading, L.P. | 2,182 | $10.6K | 0.00% | −369−14.5% | ReducedConverted for a 1-for-10 split |
| Morgan Stanley | 1,628 | $7.93K | 0.00% | −41−2.4% | ReducedConverted for a 1-for-10 split |
| Vanguard Global Advisers, LLC | 1,221 | $5.95K | 0.00% | +1,221 | New |
| Tower Research Capital LLC (TRC) | 1,152 | $5.61K | 0.00% | +913+381.0% | AddedConverted for a 1-for-10 split |
| SBI Securities Co., Ltd. | 866 | $4.22K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Royal Bank of Canada | 855 | $4.00K | 0.00% | +376+78.3% | AddedConverted for a 1-for-10 split |
| Brown Shipley& Co Ltd | 478 | $2.33K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Nisa Investment Advisors, LLC | 228 | $1.11K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Pension & Wealth Management Advisors, Inc. | 225 | $1.10K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Federated Hermes, Inc. | 73 | $356 | 0.00% | −93−55.9% | ReducedConverted for a 1-for-10 split |
| BNP Paribas Arbitrage, SA | 68 | $331 | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| The PNC Financial Services Group, Inc. | 14 | $68 | 0.00% | −0−2.8% | ReducedConverted for a 1-for-10 split |
| SHP Wealth Management | 10 | $49 | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| CWM, LLC | 4 | $19 | 0.00% | −1−25.9% | ReducedConverted for a 1-for-10 split |
| Financial Connections Group, Inc. | 30 | $0 | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −87,856−100.0% | Sold outConverted for a 1-for-10 split |
| Portolan Capital Management, LLC | 0 | $0 | 0.00% | −40,965−100.0% | Sold outConverted for a 1-for-10 split |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −13,987−100.0% | Sold outConverted for a 1-for-10 split |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −13,922−100.0% | Sold outConverted for a 1-for-10 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −9,197−100.0% | Sold outConverted for a 1-for-10 split |
| Virtu Financial LLC | 0 | $0 | 0.00% | −5,951−100.0% | Sold outConverted for a 1-for-10 split |
| Gamco Investors, Inc. Et Al | 0 | $0 | 0.00% | −5,700−100.0% | Sold outConverted for a 1-for-10 split |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −4,975−100.0% | Sold outConverted for a 1-for-10 split |
| Pasadena Private Wealth, LLC | 0 | $0 | 0.00% | −4,500−100.0% | Sold outConverted for a 1-for-10 split |
| Legato Capital Management LLC | 0 | $0 | 0.00% | −4,347−100.0% | Sold outConverted for a 1-for-10 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −4,299−100.0% | Sold outConverted for a 1-for-10 split |
| XTX Topco Ltd | 0 | $0 | 0.00% | −3,935−100.0% | Sold outConverted for a 1-for-10 split |
| Gabelli Funds LLC | 0 | $0 | 0.00% | −3,900−100.0% | Sold outConverted for a 1-for-10 split |
| Callan Family Office, LLC | 0 | $0 | 0.00% | −2,979−100.0% | Sold outConverted for a 1-for-10 split |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −2,779−100.0% | Sold outConverted for a 1-for-10 split |
| Greenwood Capital Associates LLC | 0 | $0 | 0.00% | −2,775−100.0% | Sold outConverted for a 1-for-10 split |
| Abel Hall, LLC | 0 | $0 | 0.00% | −2,528−100.0% | Sold outConverted for a 1-for-10 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −1,755−100.0% | Sold outConverted for a 1-for-10 split |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −1,703−100.0% | Sold outConverted for a 1-for-10 split |
| JustInvest LLC | 0 | $0 | 0.00% | −1,654−100.0% | Sold outConverted for a 1-for-10 split |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −1,472−100.0% | Sold outConverted for a 1-for-10 split |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,379−100.0% | Sold outConverted for a 1-for-10 split |
| Camden Capital, LLC | 0 | $0 | 0.00% | −1,368−100.0% | Sold outConverted for a 1-for-10 split |
| GSK plc | 0 | $0 | 0.00% | −1,115−100.0% | Sold outConverted for a 1-for-10 split |
| Ethic Inc. | 0 | $0 | 0.00% | −1,094−100.0% | Sold outConverted for a 1-for-10 split |
| Balboa Wealth Partners | 0 | $0 | 0.00% | −1,000−100.0% | Sold outConverted for a 1-for-10 split |
| Bank of America Corp | 0 | $0 | 0.00% | −45−100.0% | Sold outConverted for a 1-for-10 split |
| Barclays PLC | 0 | $0 | 0.00% | −2−100.0% | Sold outConverted for a 1-for-10 split |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −1−100.0% | Sold outConverted for a 1-for-10 split |
| Vanguard Group Inc | – | – | – | – | Not filed |